ERS Statement on Benign Pleural Effusions in Adults.

Autor:	Sundaralingam A; Oxford Respiratory Trials Unit, Churchill Hospital, Headington, UK Anand.Sundaralingam@ouh.nhs.uk.; Oxford Pleural Unit, Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; School of Pharmacy and Biomedical sciences, University of Portsmouth., Grabczak EM; Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw., Burra P; Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Padua University Hospital, Padua, Italy., Costa MI; Pulmonology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal., George V; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.; Hunter Medical Research Institute, Newcastle, Australia., Harriss E; Bodleian Health Care Libraries, University of Oxford, Oxford, United Kingdom., Jankowska E; Division of Translational Cardiology and Clinical Registries, Institute of Heart Diseases, Wroclaw Medical University, Poland., Janssen JP; Dept of Pulmonary Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Karpathiou G; Pathology Department, University Hospital of Saint Etienne, France., Laursen CB; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark.; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Maceviciute K; St Bartholomew's Hospital, London, UK., Maskell N; Academic Respiratory Unit, University of Bristol, Bristol, UK., Mei F; Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Italy.; Respiratory Disease Unit, University Hospital, Ancona, Italy., Nagavci B; Institute for Evidence in Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Germany., Panou V; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark.; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark., Pinelli V; Division of Pulmonology Pulmonology, ASL5 Spezzino, Italy., Porcel JM; Pleural Medicine Unit, Arnau de Vilanova University Hospital, Lleida, Spain., Ricciardi S; Division of Thoracic Surgery, San Camillo Forlanini Hospital, Rome, Italy.; PhD program Alma Mater Studiorum, University of Bologna, Bologna, Italy., Shojaee S; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center., Welch H; Academic Respiratory Unit, University of Bristol, Bristol, UK., Zanetto A; Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Padua University Hospital, Padua, Italy., Udayaraj UP; Oxford kidney Unit, Churchill hospital, Oxford, UK.; Nuffield Department of Medicine, Henry Wellcome Building for Molecular Physiology, , University of Oxford, Oxford, UK., Cardillo G; Unit of Thoracic Surgery, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.; Unicamillus, International University of Health Sciences, Rome, Italy., Rahman NM; Oxford Respiratory Trials Unit, Churchill Hospital, Headington, UK.; Oxford Pleural Unit, Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.; Chinese Academy of Medical Health Sciences, University of Oxford, Oxford, UK.
Jazyk:	angličtina
Zdroj:	The European respiratory journal [Eur Respir J] 2024 Jul 26. Date of Electronic Publication: 2024 Jul 26.
DOI:	10.1183/13993003.02307-2023
Abstrakt:	The incidence of non-malignant pleural effusions (NMPE) far outweighs that of malignant pleural effusions (MPE) and is estimated to be at least 3-fold higher. These so called "benign" effusions do not follow a "benign course" in many cases, with mortality rates matching and sometimes exceeding that of MPEs. In addition to the impact on patients, healthcare systems are significantly affected, with recent US epidemiological data demonstrating that 75% of resource allocation for pleural effusion management is spent on NMPEs (excluding empyema). Despite this significant burden of disease, and by existing at the junction of multiple medical specialties, reflecting a heterogenous constellation of medical conditions, NMPEs are rarely the focus of research or the subject of management guidelines. With this ERS Taskforce, we assembled a multi-specialty collaborative across eleven countries and three continents to provide a Statement based on systematic searches of the medical literature to highlight evidence in the management of the following clinical areas: a diagnostic approach to transudative effusions, heart failure, hepatic hydrothorax, end stage renal failure, benign asbestos related pleural effusion, post-surgical effusion and non-specific pleuritis. (Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu